l-Acetylcarnitine: A Mechanistically Distinctive and Potentially Rapid-Acting Antidepressant Drug

Current therapy of mood disorders has several limitations. Although a high number of drugs are clinically available, as of today, nearly two-thirds of individuals do not achieve full symptomatic remission after treatment with conventional antidepressants. Moreover, several weeks of drug treatment ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiechio, Santina, Canonico, Pier Luigi, Grilli, Mariagrazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795963/
https://www.ncbi.nlm.nih.gov/pubmed/29267192
http://dx.doi.org/10.3390/ijms19010011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795963/
https://www.ncbi.nlm.nih.gov/pubmed/29267192
http://dx.doi.org/10.3390/ijms19010011

Ejemplares similares